Achieve Life Sciences, Inc. (ACHV) vs Faeth Therapeutics, Inc. (FTH)
A side-by-side comparison of Achieve Life Sciences, Inc. and Faeth Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACHV
Achieve Life Sciences, Inc.
$7.20HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
FTH
Faeth Therapeutics, Inc.
$29.19HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
Total return — ACHV vs FTH
growth of $100 · dividends reinvested · last 6yACHV -42.0% (-8.7%/yr)FTH -92.8% (-35.5%/yr)ACHV compounded faster over this window
Log scale — wide-divergence pair
ACHV FTH
ACHV vs FTH: by the numbers
- •FTH is the larger company ($752M vs $739M market cap).
Metrics side by side
Valuation
| Metric | ACHV | FTH |
|---|---|---|
| P/B ratio | N/A | 4.35 |
Profitability
| Metric | ACHV | FTH |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -113.05% |
| ROIC | N/A | -110.62% |
Growth (annualized)
| Metric | ACHV | FTH |
|---|---|---|
| Total return CAGR (5Y) | -4.33% | -31.75% |
Frequently asked
- How have ACHV and FTH total returns compared?
- Over the past 5 years, ACHV delivered -4.33% and FTH delivered -31.75% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.